Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the launch of their Vector Smart™ NAM-e (North American Mosquito-East) multiplex test, which detects the eastern equine encephalitis (EEE) virus among mosquito populations, along with West Nile virus (WNV) and St. Louis encephalitis (SLE).


EEE is a mosquito-borne disease that kills roughly one-third of those infected and typically leaves survivors with “mild to severe brain damage” according to the CDC. 2019 brought an unexpected surge in cases of EEE in the US, more than 5 times the average, and the 36 confirmed cases across 8 states resulted in 14 deaths.

Mosquito populations are tested, monitored, and controlled by over 1,000 MADs (mosquito abatement districts, publicly funded departments at the city, county, and state level) in North America. The Company has been presenting its mosquito diagnostic products to MADs at vector control conferences across the country this year. Revenue from the Company’s mosquito abatement vertical began earlier in 2019, and is expected to significantly increase as demand grows for the NAM-e and other tests to help provide a first-line of defense against the spread of certain mosquito-borne illnesses.

18 infections you can get from mosquitoes

Like the other tests in the Company’s Vector Smart line of PCR products, the NAM-e test was validated using extractions from mosquito samples rather than humans and includes an extraction control specifically for mosquitoes, to reduce the possibility of a false negative result due to an improper extraction. The Company’s NAM-e test is similar to its Vector Smart NAM-w multiplex assay for WNV, SLE and western equine encephalitis (WEE), but identifies EEE instead of WEE.

“Since the launch of our NAM-w test earlier this year, developing a diagnostic tool to identify EEE has been far and away the most frequent request from this industry,” remarked Dwight Egan, CEO of Co-Diagnostics. “We were pleased to be able to quickly leverage our propriety platform and design process, and to deliver such a high-quality diagnostic to meet this demand. Co-Diagnostics is an active participant in preventing the spread of so many dangerous diseases, particularly as our Vector Smart tests are some of the only products of their kind in this market.”